Creo Medical’s device receives FDA 510(k) approval & more — 6 GI company key notes

Here are six updates on GI companies from the past week:

Advertisement

Creo Medical Group‘s Speedboat RS2 device and Croma platform received FDA 510(k) clearance.

RedHill Biopharma entered into a commercialization agreement with ParaPRO to promote RedHill’s Esomeprazole Strontium Delayed-Release capsules.

TopConsumerReviews.com awarded Bowtrol a five-star rating based on consumer feedback.

CDx Diagnostics’ Wats3D detected high-grade dysplasia and esophageal adenocarcinomas at a 400 percent higher rate when compared to the standard Seattle protocol random forceps biopsy.

Caret Pharma is acquiring Moberg Pharma AB’s Fiber Choice, a line of prebiotic fiber-based dietary supplements.

Qiagen and Clinical Genomics combined the PAXgene Blood ccfDNA Tube sample collection system into Clinical Genomics’ Colvera colorectal cancer recurrence assay.

More articles on gastroenterology:
GI center to know: Center for Colonoscopy Excellence
Metro Health adds seven gastroenterologists — 3 key notes
GI leader to know: Dr. Frank Farrell of Center for Colonoscopy Excellence

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.